Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (431-440 of 743) with videos related to

Pageof 75
Sort By:
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label studyJohn D Isaacs, Abdelrazig Salih, Thomas Sheeran, et al.
The American Journal of Medicine|November 6, 2024
Diabetic Cardiomyopathy: What Clinicians Should KnowHannah Smati, Yusuf Kamran Qadeer, Mario Rodriguez, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
Human Molecular Genetics|May 25, 2002
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerInge Søkilde Pedersen, Peter Dervan, Alo McGoldrick, et al.
The British Journal of Ophthalmology|November 1, 1995
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1HJ D Isaacs, G Hale, H Waldmann, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Profound invariant natural killer T-cell deficiency in inflammatory arthritisSusan J Tudhope, Alexei von Delwig, Jane Falconer, et al.
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
Digestive Diseases and Sciences|August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical TrialsRemo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Annals of the Rheumatic Diseases|June 2, 2016
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohortMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Pageof 75

Showing results (431-440 of 743) with videos related to

Sort By:
Pageof 75
Rheumatology Advances in Practice|August 22, 2019
Efficacy and safety of subcutaneous tocilizumab in rheumatoid arthritis over 1 year: a UK real-world, open-label studyJohn D Isaacs, Abdelrazig Salih, Thomas Sheeran, et al.
The American Journal of Medicine|November 6, 2024
Diabetic Cardiomyopathy: What Clinicians Should KnowHannah Smati, Yusuf Kamran Qadeer, Mario Rodriguez, et al.
RMD Open|February 17, 2024
Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritisPhilip M Brown, Amy E Anderson, Najib Naamane, et al.
Arthritis and Rheumatism|October 11, 2001
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopeniaJ D Isaacs, S Greer, S Sharma, et al.
Human Molecular Genetics|May 25, 2002
Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancerInge Søkilde Pedersen, Peter Dervan, Alo McGoldrick, et al.
The British Journal of Ophthalmology|November 1, 1995
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1HJ D Isaacs, G Hale, H Waldmann, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Profound invariant natural killer T-cell deficiency in inflammatory arthritisSusan J Tudhope, Alexei von Delwig, Jane Falconer, et al.
Arthritis and Rheumatism|February 2, 2008
Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomesAlice R Lorenzi, Alexandra M Clarke, Tom Wooldridge, et al.
Digestive Diseases and Sciences|August 21, 2020
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical TrialsRemo Panaccione, John D Isaacs, Lea Ann Chen, et al.
Annals of the Rheumatic Diseases|June 2, 2016
High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohortMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Pageof 75